Cyberonics builds epilepsy leadership with NeuroVista deal
This article was originally published in Clinica
Neuromodulation firm Cyberonics (Houston, Texas) has strengthened its position as leader in medical devices for treating epilepsy by executing a licensing deal with NeuroVista. The deal gives Cyberonics access to technology and patents that allow it to develop an implantable pulse generator for stimulating the vagus nerve in response to EEG-based detection of a seizure. Seattle, Washington-based NeuroVista specialises in implantable neurotechnology for the management and treatment of epilepsy. Financial terms of the deal were not revealed.